Trials / Completed
CompletedNCT01959074
The Effect of Naftopidil for the Double-J Stent Discomfort
The Effect of Naftopidil for the Double-J Stent Discomfort: Multicenter, Randomized, Double-blind, Placebo Controlled Study
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This study is To confirm the efficacy of Naftopidil for reducing discomfort of ureteral stent after urinary stone surgery.
Detailed description
1. Enrollment 1. patients underwent Double-J ureteral stent indwelling after urological surgery during less than 15 days 2. patients aged more than 20 years 2. Randomization 1. naftopidil 75 mg qd or placebo until Double-J stent removal 2. Standard treatment with pain-killers on demand were also applied.(aceclofenac) 3. Follow-up to the day of Double-J stent removal (Evaluation should be done at stent removal)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Naftopidil | Naftopidil 75mg 1T qd hs |
| DRUG | Placebo for Naftopidil | Placebo 1T qd hs |
| DRUG | Standard treatment | aceclofenac 100mg on demand |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2015-06-01
- Completion
- 2015-06-01
- First posted
- 2013-10-09
- Last updated
- 2015-12-10
Locations
6 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01959074. Inclusion in this directory is not an endorsement.